Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
10. lappuse
... Food and Drug Administra- tion's conclusions on the effectiveness of drugs are currently being published in the FEDERAL REGISTER as Drug Effi- cacy Study Implementation ( DESI ) No- tices and as Notices of Opportunity for Hearing . The ...
... Food and Drug Administra- tion's conclusions on the effectiveness of drugs are currently being published in the FEDERAL REGISTER as Drug Effi- cacy Study Implementation ( DESI ) No- tices and as Notices of Opportunity for Hearing . The ...
11. lappuse
... Food and Drug Administration at the address shown in paragraph ( e ) of this section . ( c ) Manufacturers and distributors of drugs should review their products as drug efficacy notices are published and assure that identical , related ...
... Food and Drug Administration at the address shown in paragraph ( e ) of this section . ( c ) Manufacturers and distributors of drugs should review their products as drug efficacy notices are published and assure that identical , related ...
12. lappuse
... Food and Drug Administration to the effect that an article is " not a new drug " or is “ no longer a new drug " are hereby revoked . This does not mean that all articles that were the subjects of such prior opinions will be regarded as ...
... Food and Drug Administration to the effect that an article is " not a new drug " or is “ no longer a new drug " are hereby revoked . This does not mean that all articles that were the subjects of such prior opinions will be regarded as ...
13. lappuse
... Food , Drug , and Cosmetic Act are not necessary for the protection of the public health with respect to the following drugs subject to new drug ap- plications : ( 1 ) N - Acetyl - p - aminophenol ( acetami- nophen , p - hydroxy ...
... Food , Drug , and Cosmetic Act are not necessary for the protection of the public health with respect to the following drugs subject to new drug ap- plications : ( 1 ) N - Acetyl - p - aminophenol ( acetami- nophen , p - hydroxy ...
23. lappuse
... Food and Drug Adminis- tration , 5600 Fishers Lane , Rockville , MD 20857. More than 10 copies of the form may be obtained by writing to the Consolidated Forms and Publications Distribution Center , Washington Com- merce Center , 3222 ...
... Food and Drug Adminis- tration , 5600 Fishers Lane , Rockville , MD 20857. More than 10 copies of the form may be obtained by writing to the Consolidated Forms and Publications Distribution Center , Washington Com- merce Center , 3222 ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning